Leerink Swann Downgrades Bio-Rad Labs (BIO) to Market Perform; Increased ERP Expenses Could Cap Upside
Tweet Send to a Friend
Leerink Swann downgraded Bio-Rad Labs (NYSE: BIO) from Outperform to Market Perform.
Leerink analyst says, "Our downgrade reflects a belief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink analyst says, "Our downgrade reflects a belief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
